
Rapid Micro Biosystems fell 83.8% from $4.14 to $0.67, behind the S&P 500's +10.8%. Its worst day was Mar 12 (−21.8%), and its low came Nov 5 at $0.62.
Nov 12, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Rapid Micro Biosystems shares rose 21.2%, while the S&P 500 fell 0.1%.
+21.2%, the year's best day · S&P 500 −0.1%
Story events cover the past 12 months · Times ET
Rapid Micro Biosystems closed at its highest level of the year, 13.0% above where the year started.
+0.6% · S&P 500 −0.2%
EPS of $-0.28 missed the $-0.23 estimate on $11.3M revenue (est. $10.9M); FY revenue guidance of $37.0M–$41.0M against the $39.7M consensus.
−21.8%, the year's worst day · S&P 500 −1.5%
EPS of $-0.31 missed the $-0.25 estimate on $8.0M revenue (est. $7.6M); FY revenue guidance of $37.0M–$41.0M against the $39.2M consensus.
−6.5% · S&P 500 +0.8%
Rapid Micro Biosystems shares rose 17.8%, while the S&P 500 rose 0.4%.
+17.8% · S&P 500 +0.4%
EPS of $-0.27 missed the $-0.25 estimate on $8.1M revenue (est. $7.9M); FY revenue guidance of $37.0M–$41.0M against the $39.4M consensus.
−16.8%, on 1M shares, the year's heaviest volume · S&P 500 +0.6%
Rapid Micro Biosystems closed at its lowest level of the year, 85.0% below where the year started.
−9.0% · S&P 500 −4.4%
Where it ended: a close of $0.67 on Nov 12, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.20, revenue est. $9.8M).
Nothing in the past 12 months.
All RPID dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for RPID and SPY from Benzinga historical bars. Not investment advice.